October 2, 2025
EMERYVILLE, Calif. -- Slingshot Biosciences ("Slingshot") today announced two additions to its TruCytes™ cell mimic product line designed to accelerate cell therapy and stem cell research, development, and manufacturing programs by assuring the reproducibility of results. The use of TruCytes™ Potency CD20 controls provides consistent mechanism-of-action (MoA) potency readouts, while TruCytes™ CD34 Stem Cell Gating [...]
Thermo Fisher Scientific Announces R&D Partnership with AstraZeneca BioVentureHub
October 1, 2025
WILMINGTON, N.C. -- The PPD™ clinical research business of Thermo Fisher Scientific, the world leader in serving science, today announced a new research and development (R&D) partnership with the AstraZeneca BioVentureHub in Gothenburg, Sweden. Thermo Fisher Bioanalytical lab The partnership aims to leverage the combined expertise of Thermo Fisher and AstraZeneca to drive innovation and [...]
Illumina launches new business to accelerate technology and data-driven discovery
October 1, 2025
New business focuses on developing data assets, software, and AI to fuel life science breakthroughs Expands pharma access to large omics datasets to advance target discovery and drug development SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN) today announced the launch of BioInsight, a new business within Illumina, developed to meet industry demand for deeper biologic insights driven by the need [...]
October 1, 2025
Strategic partnership provides complete automation-friendly solution for IDT NGS workflows on Hamilton’s liquid handling systems and enables user choice for solid tumor, heme comprehensive genomic profiling and more BOULDER, Colo. -- To equip users with a complete next generation sequencing (NGS) solution from sample to answer, global genomics leader Integrated DNA Technologies (IDT), together with Hamilton (Hamilton Company [...]
October 1, 2025
Funding enables company to scale its DNA synthesis services to meet accelerating demand and empower scientists to innovate across medicine, agriculture, and beyond EMERYVILLE, Calif. -- Ansa Biotechnologies, Inc., a trusted partner for DNA synthesis, today announced that it has closed $45.2 million and secured commitments for an additional $9.2 million as part of an [...]
Launching Ammonia・Nitrate Nitrogen Meter HC-200N
October 1, 2025
Supporting Research for Energy Efficiency and Greenhouse Gas Reduction in the Wastewater Treatment Industry HORIBA Advanced Techno Co., Ltd. (hereinafter referred to as “HORIBA Advanced Techno”) is pleased to announce the launch of the HC-200N Ammonia・Nitrate Nitrogen Meter on October 1, further strengthening its portfolio of industrial water quality monitoring systems. HC-200N is a product [...]
October 1, 2025
WOBURN, Mass. -- Cell X Technologies today announced a collaboration with BioLamina to integrate BioLamina's defined laminin reagents (Biolaminin®) with Cell X's Celligent™ platform, aiming to reduce variability and enhance reproducibility in advanced therapy manufacturing. This collaboration underscores the critical role of pairing automation with high-quality, standardized reagents in building scalable, reliable, and GMP-compliant workflows for [...]
October 1, 2025
New sparQ™ Lysis Kit isolates high-quality, double-stranded genomic DNA from DBS punches for PCR-free whole-genome sequencing workflows in less than 50 minutes BEVERLY, Mass. -- Quantabio, a leading provider of robust DNA and RNA amplification reagents for the most demanding molecular testing and life science research applications, today announced the launch of the sparQ™ Lysis Kit. [...]
September 30, 2025
Shimadzu Corporation has released LabSolutions Detect, a software with AI Functionality to support Anomaly Detection for Liquid Chromatographs (LC). To improve quality inspections for pharmaceuticals and food products, this software quickly detects impurity contamination by comparing LC analysis data with pre-registered data. Quality and Safety are always top priorities in each sample analysis, and it [...]
September 30, 2025
The collaboration combines multimodal database technology, advanced AI agents, and large-scale datasets to accelerate drug discovery. TileDB, Inc., Kepler AI, and Tahoe Therapeutics today announced a groundbreaking partnership to create the first public-facing platform that enables researchers to run sophisticated AI agent-based queries on massive single-cell datasets at unprecedented scale. This collaboration represents a major [...]

